Verification evidence is still being completed.
PDF / print export
Valneva Sweden
Stockholm, Sweden
- Verified lead
- Thomas Lingelbach
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer, Member of the Board of Directors
- 2026 technical specialization
- Vaccines
- Review cycle
- May 2026
- Full address
- Professional N/A
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Valneva executive team page.
- Editorial note
- Published because Valneva?s official team and contact pages confirm current leadership and a real Sweden operating footprint centred on Solna and Stockholm.
Vaccines
GMP Certified
Published because Valneva?s official team and contact pages confirm current leadership and a real Sweden operating footprint centred on Solna and Stockholm.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Stockholm, Sweden
Valneva Sweden
Vaccines · Commercial scale
Valneva Sweden runs viral vaccine production, fill & finish, and downstream processing in Stockholm, Sweden.
- Lead
- Thomas Lingelbach (verified ↗)
- Address
- Not yet on record (source ↗)
- Compliance
- GMP Certified
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Commercial scale
- Capabilities
- Viral Vaccine Production · Fill & Finish · Downstream Processing
- Founded
- 2013
- Headcount
- 1001-5000
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Thomas Lingelbach
Chief Executive Officer, Member of the Board of Directors
Full addressProfessional N/A
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Valneva contact page listing VALNEVA Sweden AB in Stockholm with the visiting address in Solna.
Open sourceCommercial scale
Stockholm, Sweden. Vaccines. Review completed on 14 Mar 2026.
MPA (Sweden)
GMP Certified
Vaccines
Published because Valneva?s official team and contact pages confirm current leadership and a real Sweden operating footprint centred on Solna and Stockholm.
Editorial note
Published because Valneva?s official team and contact pages confirm current leadership and a real Sweden operating footprint centred on Solna and Stockholm.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Viral Vaccine Production
Fill & Finish
Downstream Processing
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Industrial Bioreactors
Lyophilization Suites
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Valneva Sweden located?
- Valneva Sweden is based in Stockholm, Sweden.
- Who runs Valneva Sweden?
- Valneva Sweden is led by Thomas Lingelbach, Chief Executive Officer, Member of the Board of Directors. Verified 14 Mar 2026.
- What certifications does Valneva Sweden hold?
- Valneva Sweden is documented under GMP Certified.
- What does Valneva Sweden do?
- Valneva Sweden runs viral vaccine production, fill & finish, and downstream processing in Stockholm, Sweden. Core capabilities: Viral Vaccine Production, Fill & Finish, Downstream Processing.
Editorial context
Related technical briefs
Briefs that name Stockholm as a covered market or city.